GMMMG has subgroups as follows:

  • The High Cost Drugs Subgroup (HCDSG) will ensure the clinical and cost-effective use of existing high cost medicines (PbR tariff excluded, CCG commissioned) across the Greater Manchester health economy and it will facilitate joint working between provider trusts and CCGs on high cost drugs to ensure best use of NHS resources.
  • The Medicines and Guidelines Subgroup (MGSG) will manage the introduction of new and existing drugs to the GM formulary to ensure that the most appropriate choice of clinically and cost effective medicines are used to meet the needs of the GM population. It will undertake a review of the formulary RAG status criteria to ensure the prescribing of medicines is transferred appropriately between primary and secondary care. The group will also work with other stakeholders to facilitate the development of evidence based treatment pathways and shared care guidelines to be commissioned across the entire GM health economy.

All meeting agendas and minutes can be found on the individual subgroup pages accessible via the tab above or on the links to the left.